Stempoint Capital »

Abbvie shares owned by Stempoint Capital

Quarter-by-quarter ownership of Abbvie (ABBV) shares owned by Stempoint Capital from 13F filings

Historical chart of Stempoint Capital investment in Abbvie

Tip: Access up to 7 years of quarterly data

All positions including Abbvie held by Stempoint Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abbvie by Stempoint Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.1M 9.3k 228.49

More positions owned by Stempoint Capital

Abivax Sa Sponsored Ads (ABVX)
Scholar Rock Hldg Corp (SRRK)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Syndax Pharmaceuticals (SNDX)
Structure Therapeutics Sponsored Ads (GPCR)
Arcellx Common Stock (ACLX)
Roivant Sciences SHS (ROIV)
Terns Pharmaceuticals (TERN)
Twist Bioscience Corp (TWST)
Immunovant (IMVT)
Dyne Therapeutics (DYN)
Xenon Pharmaceuticals (XENE)
Surrozen Com New (SRZN)
Celcuity (CELC)
Mineralys Therapeutics (MLYS)

View all positions for Stempoint Capital

Top funds holding Abbvie

Vanguard Group
BlackRock
State Street Corporation
Jpmorgan Chase & Co
Geode Capital Management
Norges Bank Investment Management
Capital Research Global Investors
Charles Schwab Investment Management
Northern Trust
FMR
Franklin Resources
Goldman Sachs Group
Bank of New York Mellon
Capital World Investors
Ubs Global Asset Management Americas

View all funds holding Abbvie